A) Hardening of the arteries that occurs over a period of many years due in part to the abnormal accumulation of lipids.
B) Syndromes that encompass a continuum of clinical presentations ranging from unstable angina to non-Q-wave AMI.
C) A degenerative condition of the muscles.
D) An acute-phase reactant whose concentration in the blood rises dramatically in response to nonspecific inflammatory stimuli.
Correct Answer
verified
Multiple Choice
A) A presumptive diagnosis of heart failure in breathless patients.
B) A low risk factor for developing an acute coronary syndrome (ACS) .
C) An S-T segment myocardial infarction (STEMI) .
D) The presence of an unstable ACS in patients without increased concentration of biomarkers of necrosis, such as cTn.
Correct Answer
verified
Multiple Choice
A) Plasma adiponectin levels may predict cardiovascular events years in advance in a population without diagnosed cardiovascular disease.
B) It is an early biomarker for AMI.
C) It is a cardiac biomarker for late presenting AMIs.
D) There are two forms of this protein, pregnancy, and acute coronary syndrome; thus, adiponectin can be used for either condition.
Correct Answer
verified
Multiple Choice
A) MPO
B) CRP
C) Lp-PLA2
D) Leptin
Correct Answer
verified
Multiple Choice
A) Brain natriuretic peptide (BNP)
B) Atria natriuretic peptide (ANP)
C) Cardiac troponin T
D) Myoglobin
Correct Answer
verified
Multiple Choice
A) The toxic effect on the left ventricular wall of the heart.
B) The toxic effect of homocysteine on the adventitia or outer lining the arterial wall.
C) The toxic effect of homocysteine on the endothelial lining of the arteries, which causes plaque formation.
D) The nontoxic effect of homocysteine on the intima lining of the arteries.
Correct Answer
verified
Multiple Choice
A) Establish odds ratio, diagnosis, and treatment modalities
B) Tumor identifications, prognosis, appropriate drug therapy intervention
C) Diagnosis, monitoring, risks stratification, and therapeutic management
D) Determining life expectancy, staging diseases, population studies
Correct Answer
verified
Multiple Choice
A) Microalbumin
B) Ischemia modified albumin
C) Albumin/globulin ration
D) Serum cobalt
Correct Answer
verified
Multiple Choice
A) Diffuses into the blood more quickly than CK-MB.
B) Diffuses into the blood more slowly than CK-MB.
C) Doesn't diffuse into the blood at all when cardiac tissue dies.
D) Is an extremely large protein and therefore does not diffuse into the blood very easily.
Correct Answer
verified
Multiple Choice
A) High dose hook effect with select cTn assays
B) Modification of diagnostic cut off value for cTn assays
C) False positive and/or false negative result for BNP or NT-Pro BNP assays
D) False positive and/or false negative result for cTnI assays
Correct Answer
verified
Multiple Choice
A) Reduced risk of heart attacks.
B) Increased risk of heart attacks.
C) Increased risk of plaque rupture.
D) Stabilizing endothelial cell structure.
Correct Answer
verified
Multiple Choice
A) Acute myocardial infarctions (AMIs)
B) Tachycardia
C) Congestive heart failure
D) Pericarditis
Correct Answer
verified
Multiple Choice
A) Increased turn-around time for analysis
B) Delay in rule-out of an AMI
C) Rapid identification of AMI
D) Delay in risk stratification of an AMI
Correct Answer
verified
Multiple Choice
A) A metabolite of BNP.
B) The storage form of BNP.
C) The catabolic product of ANP.
D) The natriuretic peptide that is the inactive form.
Correct Answer
verified
Multiple Choice
A) Deficiency of one of the B complex vitamins
B) Excess of one the B complex vitamins
C) Deficiency of calcium
D) Deficiency of sodium
Correct Answer
verified
Multiple Choice
A) CK-MB, cTnI, myoglobin
B) cTnI, CK-MB, myoglobin
C) Myoglobin, CK-MB, cTnI
D) CK-MB, myoglobin, cTnI
Correct Answer
verified
Multiple Choice
A) Cardiac forms are never expressed in skeletal muscle.
B) Cardiac forms are expressed in skeletal muscle.
C) In fetal development, the cardiac and skeletal forms are co-expressed in skeletal and cardiac tissues.
D) It is the same as cardiac troponin C (cTnC) .
Correct Answer
verified
Multiple Choice
A) It competes with fibrinogen for binding sites, thus interfering with clot lysis and increasing the risk of acute myocardial infarction (AMI) .
B) It is produced by macrophages and expressed in atherosclerotic lesions.
C) It activates complement.
D) It competes with plasminogen for binding sites, thus interfering with clot lysis and increasing the risk of acute myocardial infarction (AMI) .
Correct Answer
verified
Multiple Choice
A) Unbound free fatty acid (FFAu)
B) Placental growth factor (PIGF)
C) Heart-type fatty acid binding protein (H-FABP)
D) CK-MB
Correct Answer
verified
Multiple Choice
A) Tobacco smoking, elevated serum homocysteine, low serum LDL, and high serum levels of CRP
B) Tobacco smoking, low serum homocysteine, low serum LDL, and high serum levels of CRP
C) Hypertension, abdominal obesity, low HDL-C, high serum levels of CRP, and elevated levels of homocysteine
D) Walking at least one hour per day, low serum homocysteine, low serum CRP, and low serum levels of LDL-C
Correct Answer
verified
Showing 1 - 20 of 25
Related Exams